Literature DB >> 1252813

Extrinsic allergic alveolitis in Scottish maltworkers.

I W Grant, E S Blackadder, M Greenberg, W Blyth.   

Abstract

In a survey of respiratory disease in the Scottish malting industry 5.2% of employees were found to have symptoms of extrinsic allergic alveolitis. In most cases the disease was mild and not associated with any serious respiratory disability. It was significantly less common where modern mechanical methods of malting were used. Mycological and serological studies suggested that it was usually caused by a type 3 allergic reaction to Aspergillus clavatus.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1252813      PMCID: PMC1638869          DOI: 10.1136/bmj.1.6008.490

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  2 in total

1.  Allergic alveolitis in a maltworker.

Authors:  H F Riddle; S Channell; W Blyth; D M Weir; M Lloyd; W M Amos; I W Grant
Journal:  Thorax       Date:  1968-05       Impact factor: 9.139

2.  Allergic alveolitis in maltworkers. A clinical, mycological, and immunological study.

Authors:  S Channell; W Blyth; M Lloyd; D M Weir; W M Amos; A P Littlewood; H F Riddle; I W Grant
Journal:  Q J Med       Date:  1969-10
  2 in total
  5 in total

Review 1.  Environmental control of the workplace.

Authors:  H S Novey
Journal:  Clin Rev Allergy       Date:  1988

2.  Progressive lung disease in a malt-worker.

Authors:  M E Ellis; J A Friend
Journal:  Thorax       Date:  1981-07       Impact factor: 9.139

3.  The occurrence and nature of alveolitis-inducing substances in Aspergillus clavatus.

Authors:  W Blyth
Journal:  Clin Exp Immunol       Date:  1978-05       Impact factor: 4.330

4.  Taxonomic revision of Aspergillus section Clavati based on molecular, morphological and physiological data.

Authors:  J Varga; M Due; J C Frisvad; R A Samson
Journal:  Stud Mycol       Date:  2007       Impact factor: 16.097

5.  Mutagenic and tumourigenic properties of the spores of Aspergillus clavatus.

Authors:  W Blyth; J C Hardy
Journal:  Br J Cancer       Date:  1982-01       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.